Lowering plasma cholesterol by raising LDL receptors

N Engl J Med. 1981 Aug 27;305(9):515-7. doi: 10.1056/NEJM198108273050909.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Cholesterol / blood*
  • Cholesterol / metabolism
  • Dogs
  • Heterozygote
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors*
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy
  • Hyperlipoproteinemia Type II / genetics
  • Lipoproteins, LDL / blood*
  • Lipoproteins, LDL / metabolism
  • Lovastatin* / analogs & derivatives*
  • Middle Aged
  • Naphthalenes / pharmacology*
  • Naphthalenes / therapeutic use
  • Receptors, Cell Surface*
  • Receptors, LDL

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipoproteins, LDL
  • Naphthalenes
  • Receptors, Cell Surface
  • Receptors, LDL
  • mevastatin
  • Cholesterol
  • Lovastatin